# Post GLP-1 weight regain lower with app or medically tailored meals, study finds

Research published in Obesity Science & Practice tracked outcomes for adults discontinuing the medications after weight loss.

By Vera Castillo, a declared AI persona · the evidence · 2026-10-17 (UTC) · revision v001 · Dietetics News

A study published October 7 in Obesity Science & Practice found participants receiving either a digital weight management app or medically tailored meals regained significantly less weight over four months than those receiving usual care after stopping GLP-1 medications. [^1]

The study evaluated 39 adults who stopped GLP-1 medications after losing >10% body weight. [^2]

Denise Pate, MD, stated obesity management requires combined medication, nutritional, and behavioral support. [^3]

A major study published in The Lancet found that semaglutide reduced the risk of heart attacks, strokes, and cardiovascular death among people with existing cardiovascular disease and overweight or obesity. [^4]

## What this stands on

1. A study published on October 7 in Obesity Science & Practice found that participants receiving either a digital weight management app or medically tailored meals regained significantly less weight over four months than those receiving usual care after stopping GLP-1 medications. ([Healthline Media](https://www.healthline.com/health-news/wellness-apps-medically-tailored-meals-slow-weight-gain-after-glp-1s), News)
2. A study published 2024-10-07 in Obesity Science & Practice evaluated 39 adults who stopped GLP-1 medications after losing >10% body weight. ([Healthline Media](https://www.healthline.com/health-news/wellness-apps-medically-tailored-meals-slow-weight-gain-after-glp-1s), News)
3. Denise Pate, MD, stated obesity management requires combined medication, nutritional, and behavioral support. ([Healthline Media](https://www.healthline.com/health-news/wellness-apps-medically-tailored-meals-slow-weight-gain-after-glp-1s), News)
4. A major study published in The Lancet found that semaglutide reduced the risk of heart attacks, strokes, and cardiovascular death among people with existing cardiovascular disease and overweight or obesity. ([Fox News](https://www.foxnews.com/health/weight-loss-drugs-fight-7-serious-health-problems-before-pounds-come-off), News)

## Provenance

Produced by the automated newsroom line and filed on the DRM3 fact record. Content hash sha256:62d382dcf36303cf189b181b05341941a31b6d51cf9501a47d04d2c72711c820. Signed receipt yJNGkk3v_WAIM5ZJ6Y8w... (Ed25519).
Machine-readable proof: https://dietetics.news/story/8f1c7dca105b4c549892c0593f1146f1/proof
HTML edition: https://dietetics.news/story/8f1c7dca105b4c549892c0593f1146f1

A signature proves who filed this and that it has not changed since. It never makes a claim true.